Neurology® Podcast

Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.

Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the full article in Neurology. 

Dr. Stacey Clardy interviews behavioral neurologist Dr. Daniel Drubach about his experience with being diagnosed with Lewy body dementia, highlighting the unique perspective his diagnosis has provided him as a physician and as a patient. Read Dr. Drubach's special article in Continuum: "Twilight and Me: A Soliloquy." 

The February 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and treatment of immune-mediated neuropathies. This episode features Drs. Stacey Clardy and Ted Burns in conversation with Drs. Luise Appeltshauser, Shahar Shelly, and P. James B. Dyck, offering listeners essential insight into the identification and management of acute autoimmune neuropathy, chronic immune sensory polyradiculopathy, and lumbrosacral radiculoplexus neuropathy.

Dr. Jason Crowell talks with Pulitzer Prize-winning New York Times journalist Pam Belluck about the impact of Medicare’s decision to limit patient access to aducanumab for the treatment of Alzheimer disease, restricting use to individuals in clinical trials.

Prof. Jon Stone talks with Dr. Tamara Pringsheim and Wall Street Journal columnist Julie Jargon about the increased incidence of teen girls presenting with physical tics and the potential association of exposure to TikTok videos on Tourette syndrome and functional neurologic disorder (FND).

Dr. Jeff Ratliff talks with Dr. Winston Chiong about the new AAN Position Statement on ethical considerations in the use of aducanumab for patients with Alzheimer disease.

Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy, safety, and outcomes of treating large vessel occlusion stroke with tenecteplase before thrombectomy.

Dr. Halley Alexander discusses the utility of a new systematic classification of epilepsy-related mortality used in a nationwide cohort study of children and young adults in Denmark with Dr. Marius Kløvgaard.

Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.

Dr. Halley Alexander talks with Dr. Ezequiel Gleichgerrcht about the association between the anatomical location of surgical lesions and postoperative seizure outcomes in patients with temporal lobe epilepsy.

Dr. Halley Alexander discusses the AAN Guideline Subcommittee’s practice advisory update on antiseizure medication withdrawal in seizure-free patients with Dr. Alison Pack.

Dr. Jeff Ratliff talks with Dr. Michael Alosco about the association between antemortem FLAIR white matter hyperintensities and neuropathology in brain donors exposed to repetitive head impacts.

The January 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and effects of traumatic encephalopathy syndrome (TES) and concussions. This episode features Dr. Alex Menze in conversation with Dr. Robert Stern, Dr. Nathan Churchill, and Prof. Antonio Belli, offering listeners a comprehensive understanding of the diagnosis and management of head trauma.

Celebrate the 70th Anniversary of Neurology® with Part II of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.

Celebrate the 70th Anniversary of Neurology® with Part I of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.

In the first part of the podcast, Dr. Halley Alexander discusses the effectiveness of the three first line treatments for infantile spasms with Dr. Zachary Grinspan (00:51). In the second segment, Dr. Gordon Smith talks with Dr. Ricardo Taipa about the clinical manifestations, imaging results, and neuropathological findings associated with CNS involvement in hereditary transthyretin amyloidosis (14:53).

In the first part of the podcast, Dr. Justin Abbatemarco talks with Dr. Avi Nath, Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, about COVID-19 vaccines and neurology immunotherapy (00:56). In the second segment, Dr. Andy Southerland discusses disparities in the utilization of stroke interventions with Dr. Adam de Havenon (18:18).

The December 2021 replay of past episodes showcases a selection of interviews regarding the diagnosis and management of stroke. This episode features Dr. Andy Southerland and Will Rondeau in conversation with Drs. Seemant Chaturvedi, Lee Schwamm, Jyri Virta, and Sidsel Hastrup, offering listeners a review across the field of vascular neurology.